DE60103859D1 - 2-phenylpyran-4-on derivate - Google Patents

2-phenylpyran-4-on derivate

Info

Publication number
DE60103859D1
DE60103859D1 DE60103859T DE60103859T DE60103859D1 DE 60103859 D1 DE60103859 D1 DE 60103859D1 DE 60103859 T DE60103859 T DE 60103859T DE 60103859 T DE60103859 T DE 60103859T DE 60103859 D1 DE60103859 D1 DE 60103859D1
Authority
DE
Germany
Prior art keywords
phenylpyran
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60103859T
Other languages
English (en)
Other versions
DE60103859T2 (de
Inventor
Crespo Maria Isabel Crespo
Mayorga Juan Miguel Jimenez
Julia Josep Lluis Matallana
Gras Joan Feixas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Almirall Prodesfarma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma AG filed Critical Almirall Prodesfarma AG
Publication of DE60103859D1 publication Critical patent/DE60103859D1/de
Application granted granted Critical
Publication of DE60103859T2 publication Critical patent/DE60103859T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60103859T 2000-03-16 2001-03-16 2-Phenylpyran-4-on Derivat Expired - Lifetime DE60103859T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200000637 2000-03-16
ES200000637 2000-03-16
PCT/EP2001/003042 WO2001068633A1 (en) 2000-03-16 2001-03-16 2-phenylpyran-4-one derivatives

Publications (2)

Publication Number Publication Date
DE60103859D1 true DE60103859D1 (de) 2004-07-22
DE60103859T2 DE60103859T2 (de) 2005-07-21

Family

ID=8492732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60103859T Expired - Lifetime DE60103859T2 (de) 2000-03-16 2001-03-16 2-Phenylpyran-4-on Derivat

Country Status (27)

Country Link
US (1) US7354936B2 (de)
EP (1) EP1263751B1 (de)
JP (1) JP2003527389A (de)
KR (1) KR20030005221A (de)
CN (1) CN1429221A (de)
AR (1) AR030410A1 (de)
AT (1) ATE269316T1 (de)
AU (1) AU2001254692A1 (de)
BG (1) BG107101A (de)
BR (1) BR0109252A (de)
CA (1) CA2403149A1 (de)
CZ (1) CZ20023058A3 (de)
DE (1) DE60103859T2 (de)
EE (1) EE200200528A (de)
ES (1) ES2223830T3 (de)
HK (1) HK1048117A1 (de)
HU (1) HUP0301696A2 (de)
IL (1) IL151598A0 (de)
MX (1) MXPA02009016A (de)
NO (1) NO20024393L (de)
NZ (1) NZ521187A (de)
PE (1) PE20011333A1 (de)
PL (1) PL358062A1 (de)
RU (1) RU2002127728A (de)
SK (1) SK12832002A3 (de)
WO (1) WO2001068633A1 (de)
ZA (1) ZA200207184B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465509B2 (en) 2000-06-30 2002-10-15 Merck Frosst Canada & Co. Pyrones as inhibitors of cyclooxygenase-2
ES2213485B1 (es) * 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
CN102731456B (zh) * 2011-04-01 2014-07-09 华中科技大学 一种抗肿瘤化合物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH523257A (de) 1969-12-31 1972-05-31 Ciba Geigy Ag Verfahren zur Herstellung von neuen Imidazolderivaten
US3901908A (en) 1970-12-28 1975-08-26 Ciba Geigy Corp 2-alkyl- and 2-cycloalkyl-4,5-bis-phenyl-imidazoles
US4304728A (en) 1979-04-05 1981-12-08 Lilly Industries Limited 6-Substituted pyranone compounds and their use as pharmaceuticals
IL59748A (en) 1979-04-05 1983-11-30 Lilly Industries Ltd 5-substituted pyranone derivatives,their production and pharmaceutical compositions containing them
US6048850A (en) 1992-09-22 2000-04-11 Young; Donald A. Method of inhibiting prostaglandin synthesis in a human host
RU2153497C2 (ru) * 1993-11-19 2000-07-27 Парк,Дэвис Энд Компани Производные пирона, фармацевтическая композиция с антивирусной и антибактериальной активностью на их основе и способ лечения вызванных ретровирусом инфекции или заболевания
US5521213A (en) 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
US5541204A (en) 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
NZ304886A (en) 1995-04-04 1998-11-25 Glaxo Group Ltd Imidazo [1,2a] pyridine derivatives, preparation and pharmaceutical compositions thereof
CA2307111C (en) 1997-11-19 2009-06-30 Kowa Co., Ltd. Novel pyridazine derivatives and drugs containing the same as the active ingredient
TW587079B (en) * 1998-09-25 2004-05-11 Almirall Prodesfarma Ag 2-phenylpyran-4-one derivatives

Also Published As

Publication number Publication date
RU2002127728A (ru) 2004-03-20
CA2403149A1 (en) 2001-09-20
ATE269316T1 (de) 2004-07-15
US7354936B2 (en) 2008-04-08
CN1429221A (zh) 2003-07-09
NO20024393L (no) 2002-11-13
US20030232880A1 (en) 2003-12-18
EE200200528A (et) 2004-04-15
EP1263751A1 (de) 2002-12-11
BR0109252A (pt) 2002-12-24
AR030410A1 (es) 2003-08-20
EP1263751B1 (de) 2004-06-16
MXPA02009016A (es) 2004-10-15
HK1048117A1 (zh) 2003-03-21
ZA200207184B (en) 2003-12-08
WO2001068633A1 (en) 2001-09-20
BG107101A (bg) 2003-07-31
ES2223830T3 (es) 2005-03-01
IL151598A0 (en) 2003-04-10
JP2003527389A (ja) 2003-09-16
AU2001254692A1 (en) 2001-09-24
PL358062A1 (en) 2004-08-09
KR20030005221A (ko) 2003-01-17
NO20024393D0 (no) 2002-09-13
SK12832002A3 (sk) 2003-11-04
NZ521187A (en) 2004-03-26
DE60103859T2 (de) 2005-07-21
HUP0301696A2 (hu) 2003-09-29
CZ20023058A3 (cs) 2004-01-14
PE20011333A1 (es) 2002-01-16

Similar Documents

Publication Publication Date Title
ATE261933T1 (de) Admantan derivate
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
DE60120366D1 (de) Arylkondensiete azapolycyclische derivate
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
ATE273980T1 (de) 6-phenylpyrrolopyrimidindion derivate
ATE298332T1 (de) Decahydro-isochinolinderivate
DK1280809T3 (da) Antitumorecteinascidinderivater
DE60013127D1 (de) 5-phenyl-pyrimidine derivate
DE50114491D1 (de) Substituierte C-Cyclohexylmethylamin-Derivative
AR028602A1 (es) Derivados de pirrol
AR028282A1 (es) Derivados de aminofenil pirimidona
ATE317389T1 (de) 4-phenyl-pyrimidine derivate
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
DK1246791T3 (da) Aminomethyl-phenyl-cyklohexanonderivater
DE60143905D1 (de) Phtalazinon derivate
DK1322590T3 (da) Substituerede 5-amino-1-penten-3-ol-derivater
ATE269316T1 (de) 2-phenylpyran-4-on derivate
ATE374776T1 (de) Pyrrolotriazolopyrimidinonderivate
DK1246793T3 (da) Substituerede aminomethyl-phenyl-cyclohexanderivater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ALMIRALL AG, BAAR, CH

8327 Change in the person/name/address of the patent owner

Owner name: LABORATORIOS ALMIRALL, S.A., BARCELONA, ES